Tesla
TSLA
Taiwan Semiconductor
TSM
Disney
DIS
4
Adobe
ADBE
5
Apple
AAPL
US Stock MarketDetailed Quotes
SUPN Supernus Pharmaceuticals
- 31.660
- +0.120+0.38%
Trading May 9 10:32 ET
1.77BMarket Cap28.57P/E (TTM)
32.220High31.215Low51.96KVolume31.540Open31.540Pre Close1.66MTurnover0.11%Turnover Ratio23.98P/E (Static)55.99MShares40.28052wk High1.72P/B1.54BFloat Cap25.53052wk Low--Dividend TTM48.66MShs Float61.250Historical High--Div YieldTTM3.19%Amplitude4.300Historical Low31.887Avg Price1Lot Size
Supernus Pharmaceuticals Key Stats
EPS
According to the latest financial report of Supernus Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.21. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Supernus Pharmaceuticals's free cash flow? The latest report shows it as 30.27M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Supernus Pharmaceuticals shows that the company's current ratio is 2.44, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Supernus Pharmaceuticals, the quick ratio is 2.16, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Supernus Pharmaceuticals? The latest ROE figure is -1.14%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Supernus Pharmaceuticals, the total asset return on investment (ROA) is -0.87%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Supernus Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 89.48%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Supernus Pharmaceuticals, the net profit margin is -7.89%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025